Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection

Improved understanding of the dynamics of host immune responses and viral evolution is critical for effective HIV-1 vaccine design. We comprehensively analyzed Cytotoxic T-lymphocyte (CTL)-viral epitope dynamics in an antiretroviral therapy-naïve subject over the first four years of HIV-1 infection. We found that CTL responses developed sequentially and required constant antigenic stimulation for maintenance. CTL responses exerting strong selective pressure emerged early and led to rapid escape, proliferated rapidly and were predominant during acute/early infection. Although CTL responses to a few persistent epitopes developed over the first two months of infection, they proliferated slowly. As CTL epitopes were replaced by mutational variants, the corresponding responses immediately declined, most rapidly in the cases of strongly selected epitopes. CTL recognition of epitope variants, via cross-reactivity and de novo responses, was common throughout the period of study. Our data demonstrate that HIV-specific CTL responses, especially in the critical acute/early stage, were focused on regions that are prone to escape. Failure of CTL responses to strongly target functional or structurally critical regions of the virus, as well as the sequential cascade of CTL responses, followed closely by viral escape and decline of the corresponding responses, likely contribute to a lack of sustainable viral suppression. Focusing early and rapidly proliferating CTL on persistent epitopes may be essential for durable viral control in HIV-1 infection.

[1]  J. Mullins,et al.  Conserved HIV-1 epitopes continuously elicit subdominant cytotoxic T-lymphocyte responses. , 2009, The Journal of infectious diseases.

[2]  Alan S. Perelson,et al.  The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.

[3]  Eric J. Arts,et al.  Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response , 2009, PLoS pathogens.

[4]  R. Kaul,et al.  Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection , 2008, The Journal of experimental medicine.

[5]  S. Oka,et al.  Different Abilities of Escape Mutant-Specific Cytotoxic T Cells To Suppress Replication of Escape Mutant and Wild-Type Human Immunodeficiency Virus Type 1 in New Hosts , 2007, Journal of Virology.

[6]  D. Shriner,et al.  Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape , 2007, Journal of Virology.

[7]  E. Wherry,et al.  Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection , 2007, The Journal of experimental medicine.

[8]  O. Yang,et al.  Epitope-Dependent Avidity Thresholds for Cytotoxic T-Lymphocyte Clearance of Virus-Infected Cells , 2007, Journal of Virology.

[9]  Eric S. Rosenberg,et al.  Selective Depletion of High-Avidity Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ T Cells after Early HIV-1 Infection , 2007, Journal of Virology.

[10]  D. Shriner,et al.  Evolution of HIV-1 CTL epitopes: Fitness-Balanced Escape , 2007 .

[11]  David C. Nickle,et al.  Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection , 2006, Journal of Virology.

[12]  Todd M. Allen,et al.  Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. , 2006, The Journal of infectious diseases.

[13]  G. Freeman,et al.  Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.

[14]  David Heckerman,et al.  Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes , 2006, Nature Immunology.

[15]  Christian Brander,et al.  Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution , 2005, Journal of Virology.

[16]  Philip J. R. Goulder,et al.  HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL Response1 , 2005, The Journal of Immunology.

[17]  M. Nowak,et al.  Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response , 2004, The Journal of experimental medicine.

[18]  E. Wherry,et al.  Antigen-independent memory CD8 T cells do not develop during chronic viral infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Bette Korber,et al.  Epitope Escape Mutation and Decay of Human Immunodeficiency Virus Type 1-Specific CTL Responses 1 , 2003, The Journal of Immunology.

[20]  Jianhong Cao,et al.  Evolution of CD8+ T Cell Immunity and Viral Escape Following Acute HIV-1 Infection1 , 2003, The Journal of Immunology.

[21]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[22]  Lawrence Corey,et al.  Comprehensive Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon-Secreting CD8+ T Cells in Primary HIV-1 Infection , 2003, Journal of Virology.

[23]  B. Korber,et al.  HIV sequence compendium 2002 , 2002 .

[24]  J. Lieberman,et al.  Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. , 2001, Blood.

[25]  F. Buseyne,et al.  The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes. , 2001, International immunology.

[26]  R. Welsh Assessing Cd8 T Cell Number and Dysfunction in the Presence of Antigen , 2001, The Journal of experimental medicine.

[27]  E. Rosenberg,et al.  Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection , 2001, The Journal of experimental medicine.

[28]  K. Hirayama,et al.  A single CTL clone can recognize a naturally processed HIV‐1 epitope presented by two different HLA class I molecules , 2000, European journal of immunology.

[29]  M A Nowak,et al.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.

[30]  P. Klenerman,et al.  Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[32]  Martin A. Nowak,et al.  Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.

[33]  G. Shaw,et al.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.

[34]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.

[35]  D. Hartl,et al.  Principles of population genetics , 1981 .